Skip to main content
Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
|
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
Quick Search
Current Opinion in Drug Discovery & Development
BioMed Central
PubMed Central
PubMed
Jump to article
vol.
page no.
Current Opinion in Drug Discovery & Development
Home
Journal site
Advanced search
Archive
About this journal
Most viewed
Article alerts
Current Opinion in Drug Discovery & Development, Volume 12, Issue 4 (July 2009)
[
more info
]
Current Opinion in Drug Discovery & Development is published bimonthly and focuses on the chemical aspects of drug discovery and development.
Access to the full text or PDF of articles from
Current Opinion in Drug Discovery & Development
requires a
subscription
to the journal.
previous issue
Patent alert
Reuters Current Awareness Analysts Thomson
Current Opinion in Drug Discovery and Development
2009,
12
:435-439
(24
June
2009)
[
PDF
]
Web alert
MA Stidham
Current Opinion in Drug Discovery and Development
2009,
12
:440-442
(24
June
2009)
[
PDF
]
Personalized medicine
A paradigm for a sustainable pharmaceutical industry?
S Chackalamannil, MC Desai
Current Opinion in Drug Discovery and Development
2009,
12
:443-445
(24
June
2009)
[
PDF
]
Recent progress in the discovery and development of negative allosteric modulators of mGluR5
CW Lindsley, KA Emmitte
Current Opinion in Drug Discovery and Development
2009,
12
:446-457
(24
June
2009)
[
PDF
]
PDE10A inhibitors: An assessment of the current CNS drug discovery landscape
T Chappie, J Humphrey, F Menniti, C Schmidt
Current Opinion in Drug Discovery and Development
2009,
12
:458-467
(24
June
2009)
[
PDF
]
Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification
DC Javitt
Current Opinion in Drug Discovery and Development
2009,
12
:468-478
(24
June
2009)
[
PDF
]
Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection
J Bonfanti, D Roymans
Current Opinion in Drug Discovery and Development
2009,
12
:479-487
(24
June
2009)
[
PDF
]
The importance of drug-target residence time
R Zhang, F Monsma
Current Opinion in Drug Discovery and Development
2009,
12
:488-496
(24
June
2009)
[
PDF
]
Physiologically based pharmacokinetic (PBPK) modeling and simulation: Applications in lead optimization
SA Peters, AL Ungell, H Dolgos
Current Opinion in Drug Discovery and Development
2009,
12
:509-518
(24
June
2009)
[
PDF
]
GPR119 agonists: A promising new approach for the treatment of type 2 diabetes and related metabolic disorders
U Shah
Current Opinion in Drug Discovery and Development
2009,
12
:519-532
(24
June
2009)
[
PDF
]
Is there a future for Aurora kinase inhibitors for anticancer therapy?
P Carpinelli, J Moll
Current Opinion in Drug Discovery and Development
2009,
12
:533-542
(24
June
2009)
[
PDF
]
Erratum [Fungal biotransformations of cannabinoids: Potential for new effective drugs. CODDD (2009) 12(2):305-312. Correction: the structure of chrysanthenol that appears in Figures 3 and 4]
Current Opinion in Drug Discovery and Development
2009,
12
:562
(24
June
2009)
[
PDF
]
previous issue
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.